December 17, 2012 -- The management of ICRC-Weyer GmbH looks back at a successful year 2012, with a number of new collaborations and partnerships in the area of outsourcing clinical services.
According to J. Daniel Weyer, Managing Director at ICRC-Weyer, the success results from the hard work of a devoted team combined with the company’s constant enhancements to their existing services portfolio. ‘A lot has happened this year’ says Mr Weyer. ‘We have successfully adjusted our clinical services for health claim trials as a response to new regulations by the European Parliamentary Committee on Environment, Public Health and Food Safety (ENVI). With this adjustment, we are now an expert provider of clinical services for manufacturers of dietary supplements and functional foods‘.
ICRC-Weyer has furthermore enhanced its medical data management services and introduced new medical coding procedures in 2012, enabling the CRO to deliver expert services by knowledgeable medical staff in the areas of manual medical data validation, medical coding as well as planning and organisation of ICRC-Weyer’s specialist medical review services.
‘One of the key adjustments in our services portfolio was the extension of our clinical monitoring services to monitoring for trials in the area of stem cell research’ Mr Weyer continues. ‘With this new feature we were able to establish new partnerships with pharmaceutical companies in the field of regenerative medicine’.
ICRC-Weyer participated in a number of industry events such as the 13th Euroforum Annual Conference on Nutrition, the AGAH Annual Meeting in Leipzig, the Evolution Summit in Munich as well as the EMWA Conference in Berlin. The company furthermore introduced a new communication strategy by starting to engage in discussions on the large social networks such as LinkedIn, Facebook and Google+ with industry professionals and people generally interested in clinical research. The company also grew in size, with new employees reinforcing the team in various clinical departments.
‘All in all, it was a very successful year, and we look forward to continuing this trend in 2013. We would like to thank all our employees for their hard work as well as our clients, partners and stakeholders.’
ICRC-Weyer is an established all-phase contract research organization (CRO) based in Berlin, Germany. The company was founded in 1993 by Prof. Dr. Geerd Weyer and offers services ranging from pre-clinical through to phase IV clinical trials. ICRC-Weyer provides complete turnkey solutions including data management, monitoring and medical review services for all stages of the clinical development process. ICRC-Weyer has special expertise in Advanced Therapies, Nutrition, CDISC Data Standards and Medical Review.